Gubra A/S (FRA:PI3)

Market Cap	878.87M +7.6%
Revenue (ttm)	36.25M -89.7%
Net Income	-24.38M
EPS	-1.49
Shares Out	n/a
PE Ratio	n/a
Forward PE	87.59
Dividend	n/a
Ex-Dividend Date	n/a

Volume	135
Open	55.50
Previous Close	52.75
Day's Range	54.25 - 55.50
52-Week Range	41.76 - 73.15
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 20, 2026

About Gubra

Gubra A/S, a disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally. It operates through three segments: Preclinical Contract Research (CRO), Biotech, and Gubra Green. The company offers preclinical contract research and development services within metabolic and fibrotic diseases for the pharmaceutical and biotechnology industry; and various services in vivo pharmacology, biomarker assays, bioinformatics, next gen sequencing, bioinfor...

• Industry: Commercial Physical and Biological Research
• Founded: 2008
• Employees: 330
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: PI3

Financial Performance

Financial numbers in DKK

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 27, 2026

Data Sources Report a data error